Percheron Therapeutics Ltd
ASX:PER
Percheron Therapeutics Ltd
ASX:PER
Price:
0.007
AUD
Market Closed
Market Cap:
AU$7.6m
Relative Value
The Relative Value of one
PER
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.007 AUD,
Percheron Therapeutics Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PER Relative Value
HIDDEN
Multiples Across Competitors
PER Competitors Multiples
Percheron Therapeutics Ltd Competitors
Percheron Therapeutics Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Percheron Therapeutics Ltd
ASX:PER
|
7.6m AUD | 20.5 | -0.5 | 0.2 | 0.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
953.8B USD | 14.8 | 46.6 | 31.5 | 33.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
584.6B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
290.5B CHF | 4.7 | 30.9 | 13 | 15.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
245.6B CHF | 5.6 | 22.7 | 14 | 18 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.2B GBP | 5.4 | 30.8 | 17.1 | 24.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.8B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.5B USD | 2.6 | 17.4 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
